Browsing Tag
Novo Holdings
8 posts
Why is Avalyn Pharma going public now, and what does it reveal about biotech risk appetite?
Avalyn Pharma has filed for a U.S. IPO to fund inhaled pulmonary fibrosis drugs. Read what the move signals for biotech markets and lung disease therapy.
KKR and Novo Holdings double down on Sylvan to scale fungal biotechnology across Asia
KKR and Novo Holdings reinvest in Sylvan to scale fungal biotech in Asia. Find out what this means for industrial bio-platforms and global investors.
Novo Holdings acquires 60% stake in Single Use Support to bolster biopharma innovations
In a strategic move to enhance its presence in the biopharmaceutical sector, Novo Holdings A/S has secured a…
Novo Nordisk announces $11bn acquisition of fill-finish sites to boost global manufacturing
In a strategic move to enhance its global manufacturing capabilities, Novo Nordisk has announced a significant acquisition from…
Hemab Therapeutics raises $135m for prophylactic treatments for bleeding and thrombotic disorders
Hemab Therapeutics, a clinical-stage biotechnology company, has raised $135 million in a Series B financing round for advancing…
Elo Life Systems secures $24.5m for natural, plant-based sweetener products
Elo Life Systems, a US-based food ingredient manufacturer, has raised $24.5 million, closing its Series A financing round,…
French biotech company Amolyt Pharma Series C round fetches $138m
Amolyt Pharma, a France-based clinical-stage biotechnology company, has secured €130 million (around $138 million) from a Series C…
AI drug discovery company Exscientia raises $60m in Series C round
Exscientia, a UK-based artificial intelligence (AI) drug discovery company, has secured $60 million in a Series C financing…